10 doctors weighed in:
For brain cancer what is the typical survival rate grade 3 anaplastic astrocytoma. All I have found is 3-5 years ?
10 doctors weighed in

Dr. Allen Seely
General Practice
5 doctors agree
In brief: MAY be longer
My wife had a 6cm grd 3 astrocytoma in 2000.
She had surgery, radiation and chemo. She remains in remission.

In brief: MAY be longer
My wife had a 6cm grd 3 astrocytoma in 2000.
She had surgery, radiation and chemo. She remains in remission.
Dr. Allen Seely
Dr. Allen Seely
Thank
1 comment
Dr. Allen Seely
My wife's web page http://www.caringbridge.org/visit/teresaseely
Dr. Devon Webster
Internal Medicine - Oncology
3 doctors agree
In brief: That's right
I'm sorry to tell you that 3-5 years is right, but remember that's an average.
That means some people live longer than 5 years, and some don't live as long as 3 years. Each person is different, and survival depends on many factors. Ask your doctor to be honest with you along the way, and keep hoping... There are new treatments for astrocytoma every day! best wishes!

In brief: That's right
I'm sorry to tell you that 3-5 years is right, but remember that's an average.
That means some people live longer than 5 years, and some don't live as long as 3 years. Each person is different, and survival depends on many factors. Ask your doctor to be honest with you along the way, and keep hoping... There are new treatments for astrocytoma every day! best wishes!
Dr. Devon Webster
Dr. Devon Webster
Thank
Dr. Jefferson Chen
Neurosurgery
In brief: Generally true
There are many new molecular markers for the grade 3 anaplastic astrocytoma that suggest that the outcomes may be improved.
One of the newest is the idh1/2 set of mutations. The astrocytomas that have these have a better response to the treatments and have a longer survival rate. There are new targeted therapies against the hedgehog genes that hold some promise. Keep watching for trials.

In brief: Generally true
There are many new molecular markers for the grade 3 anaplastic astrocytoma that suggest that the outcomes may be improved.
One of the newest is the idh1/2 set of mutations. The astrocytomas that have these have a better response to the treatments and have a longer survival rate. There are new targeted therapies against the hedgehog genes that hold some promise. Keep watching for trials.
Dr. Jefferson Chen
Dr. Jefferson Chen
Thank
Dr. Chakshu Gupta
Pathology
In brief: Options
3-5 is median survival - so it can be more or less in different individuals.
Ask your doctor if there is an "oligo" component in the astrocytoma, which makes the tumor more responsive to radiation. Also ask if a mgmt mutation study may be indicated in this case.

In brief: Options
3-5 is median survival - so it can be more or less in different individuals.
Ask your doctor if there is an "oligo" component in the astrocytoma, which makes the tumor more responsive to radiation. Also ask if a mgmt mutation study may be indicated in this case.
Dr. Chakshu Gupta
Dr. Chakshu Gupta
Thank
Get help from a real doctor now
Dr. Peter Kurzweil
Board Certified, Internal Medicine
46 years in practice
16M people helped
Continue
107,000 doctors available
Read more answers from doctors